TOKYO -- A Japanese team testing the flu drug Avigan as a treatment for the new coronavirus said Wednesday more time was needed to determine its effectiveness, while the government stood by a goal of approving the medication's use this month.
The Fujita Health University School of Medicine said it will continue clinical trials based on the recommendation of an independent panel. The panel found "no safety or other problems" associated with the trials, according to Yohei Doi, the microbiologist heading the effort.
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
